Русский
English
عربي
Orchidia Pharmaceutical Industries
By 2020, Orchidia expanded its production of cosmeceuticals and nutraceuticals through the introduction of premium products and advanced technologies.
Orchidia is certified for WHO-GMP implementation by the Egyptian Drug Authority (EDA) and other regulatory bodies in the Middle East and Africa. It also holds ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 17025:2017, ISO 13485:2016 certifications, as well as the European CE marking. The company continuously maintains and improves its Quality Management Systems (QMS) and Environmental, Health, and Safety (EHS) practices to achieve the required quality standards and exceed stakeholder expectations.
Its current portfolio includes 60 ophthalmic products and 11 medical devices, 8 of which are CE certified. In addition to a wide range of various ophthalmic products in different pharmaceutical forms, Orchidia’s CE-marked products are registered with the Belgian Ministry of Health by SGS Belgium 1639 and represented in Germany by MDSS (Medical Device Safety Services).
Orchidia’s products are available beyond national borders in 40 countries, primarily in the Middle East and Africa regions. The company is also in the process of registering in several additional countries.
Brand products
